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Abstract Protein design is currently used for the creation of
new proteins with desirable traits. In our lab, we focus on the
synthesis of proteins with high essential amino acid content,
having potential application in animal nutrition. One of the
limitations we face in this endeavor is the achievement of stable
proteins in spite of a highly biased amino acid content. We report
here the synthesis and characterization of MB-1Trp, a protein
with a tailored content in selected essential amino acids. The
protein is a Tyr62-Trp mutant of the parent molecule MB-1
described earlier. The new protein is largely helical as per design,
is well folded, and has a melting temperature of 55‡C. Its
resistance to proteolytic degradation compares to that of
cytochrome c, a protein of similar size. Design strategy used
for MB-1Trp is discussed with regards to its applicability toward
the creation of efficient nutritional proteins. ß 2000 Federation
of European Biochemical Societies. Published by Elsevier Sci-
ence B.V. All rights reserved.
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1. Introduction
De novo design of arti¢cial proteins has been an emerging
area of research that tests our understanding of protein struc-
ture and allows the creation of macromolecules with desirable
and speci¢c structures and properties. The property that we
(and other groups) have chosen is the nutritional quality of
protein, in view of its importance for animal production and
human health [1^5].
In our lab, we have been interested in nutritional value,
focusing on proteins with an essential amino acids (EAA)
pro¢le tailored for dairy animal production. Our ¢rst de
novo designed protein, Milk Bundle-1 (MB-1), has been re-
ported earlier [1]. Characterization of MB-1 indicated that the
design process used resulted in the stable expression of a new,
largely helical protein enriched in the selected EAA (60% in
M, T, K and L). After a ¢rst round of design, the protein
MB-1 was found to have a folded core and low a⁄nity for 8-
anilino-1-naphthalenesulfonic acid (ANSA) [4]. Its behavior
and expression levels in vivo were found to be far superior
to earlier attempts in the area of high EAA polypeptide design
[6].
Investigation of MB-1’s properties did reveal some £aws,
however. The proteins appear to associate into dimers that
could dissociate into monomers in the presence of a high
salt concentration [4]. Its melting temperature was found to
be very low (39‡C), and its resistance to proteases at a phys-
iological temperature was also found to be limited, a possible
consequence of partial unfolding [6]. As a consequence of
these weaknesses, e¡orts in growing crystals were unsuccessful
[7].
In order to improve MB-1’s folding and resistance to deg-
radation, strategies for a new cycle of design were considered.
One possible modi¢cation involved the sole Tyr in position
62, predicted to be buried in the hydrophobic core. This spec-
tral probe has been useful on two counts: it permitted the
con¢rmation of protein purity using £uorescence, and it has
been used as a conformational probe, as it was indeed buried
as planned [6]. Burial of a hydroxyl group in the core is a
potential source of destabilization, however, and may have
contributed to MB-1’s poor behavior in terms of stability
[6]. Replacement of Tyr62 by Trp should provide increased
hydrophobicity to the protein core, and would maintain, if
not expand, the useful spectroscopic properties of the side
chain in position 62. In this paper, we report the substitution
of Tyr62 by Trp and the impact of this mutation on a number
of structural features, including thermostability.
2. Materials and methods
2.1. Preparation of MB-1Trp mutant
Substitution of the Tyr in position 62 by a Trp was performed using
the oligo-directed mutagenesis kit ‘Altered Sites0 II’ (Promega). The
mutational oligonucleotide Tyr62-Trp (shown below with the corre-
sponding MB-1 sequences) was purchased from Gibco BRL/Life
Technologies, puri¢ed using denaturing polyacrylamide gel electro-
phoresis (PAGE) and phosphorylated.
MB-1: 5P-ATG GCC ACT ACG TAC TTC AAA ACG ATG-3P
Tyr62-Trp: 5P-ATG GCC ACT ACG TGG TTC AAA ACG
ATG-3P
The mutation was then con¢rmed by dideoxynucleotide sequencing
using T7 Sequenase kit (Amersham Life Science). The mutated MB-1
gene was cloned back in the pCMG20 4-X expression vector [1] and
positive clones were checked again by DNA sequencing.
2.2. Protein expression and puri¢cation
Bacteria carrying the mutant vectors were grown at 37‡C, 300 rpm
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in 1 l of LB Miller medium (Difco) to an optical density (OD) of 0.4.
Transcription was induced using 1 mM isopropylthio-L-D-galactoside
for 3 h. The cells were then harvested by centrifugation at 3000Ug.
The puri¢cation procedure was essentially as described in [1] with
minor modi¢cations. Precipitated cells were resuspended in ice-cold
column bu¡er (10 mM Tris, 200 mM NaCl, 10 mM ethylenedi-
aminetetraacetate (EDTA), 1 mM sodium azide (NaN3), pH 7.4).
Phenylmethylsulfonyl£uoride, ethylene glycol-bis(L-aminoethylether)-
N,N,NP,NP-tetraacetate, benzamidine-hydrochloride and benzamide
were added to a ¢nal concentration of 0.1, 10, 2 and 2 mM, respec-
tively. Cells were then lysed by 10 30 s sonication pulses using a
Branson Soni¢er 250 at 60% output control. The sonicate was centri-
fuged at 11 500Ug for 30 min at 4‡C.
The supernatant was then loaded onto a 15 ml amylose column.
The maltose binding protein (MBP) fused with MB-1Trp (MBP-MB-
1Trp) was eluted by washing the column with column bu¡er contain-
ing 10 mM maltose (elution bu¡er). Pooled peak fractions were placed
in dialysis tubing (Spectra/Por; molecular weight cut o¡ 3500 Da)
with 50 Wl factor Xa per 10 ml fusion protein. The bag was placed
in 20 mM Tris, 100 mM NaCl, 3 mM CaCl2 (cleavage bu¡er) over-
night at 4‡C. The following morning, the bag was transferred to 10
mM Tris^1 mM EDTA (TE) bu¡er, pH 8.0. After a 2 h dialysis, the
sample was applied to DEAE-Sepharose equilibrated in TE bu¡er, pH
8.0 (Fast Flow; Pharmacia) and washed with the same bu¡er. MB-
1Trp was collected as the £ow-through. The di¡erent fractions were
analyzed for protein content by the bicinchoninic acid (BCA) assay
and the positive fractions were pooled and concentrated using BIO-
MAX-5K concentrators (Millipore). Protein samples were prepared in
a borate-phosphate bu¡er (55 mM NaH2PO4, 35 mM Na2B4O7, pH
6.8) and dialyzed overnight against this bu¡er prior to measurements.
Protein concentration was adjusted to 0.4 mg/ml unless speci¢ed
otherwise.
2.3. Protein quanti¢cation and electrophoresis
Protein concentration was determined by the BCA assay (Sigma),
using bovine serum albumin as the standard. The protein was visual-
ized by sodium dodecyl sulfate (SDS)^PAGE using 12% polyacryl-
amide^tricine gels, followed by silver nitrate staining. SDS^PAGE
experiments were conducted prior to measurements to con¢rm protein
purity.
2.4. Conformational investigation by circular dichroism (CD)
Protein samples were degassed for 20 min at 20‡C before measure-
ments. Spectra were measured with a Jasco J-720 spectropolarimeter,
which was routinely calibrated with a 0.06% (w/v) ammonium (+)-10-
camphorsulfonate solution. For measurements in the far-UV region, a
quartz cell with a path length of 0.01 cm was used. Ten scans were
accumulated at a scan speed of 20 nm per minute, with data being
collected at every nm from 180 to 260 nm. Sample temperature was
maintained at 20‡C using a Neslab RTE-111 circulating water bath
connected to the water-jacketed quartz cuvettes. Spectra were cor-
rected for bu¡er signal and conversion to vO (on the basis of amide
bond concentration) was performed with the Jasco Standard Analysis
software. Secondary structure calculations were performed using the
CDsstr program developed [8], using default settings.
2.5. Thermal denaturation
Samples were prepared as described in the preceeding Section 2.4.
In order to measure thermostability, temperature was increased from
15 to 85‡C at a rate of 30‡C per hour using a Neslab RTE-11 con-
trolled by the Jasco spectropolarimeter software. CD spectra were
collected at every 5‡C, from 200 to 260 nm, at a scan speed of 20
nm/min. In order to assess reversibility of thermal denaturation, the
protein solutions were cooled down at a rate of 30‡C per hour, and
spectra were measured at 70, 50 and 20‡C.
Thermal stability was calculated assuming a unimolecular, two-state
process as previously described [9]. The vOMRW at 222 nm measured at
various temperatures was used as the property (y) indicative of the
extent of unfolding. In the folded state, the parameter y = yf and the
fraction of folded protein ff is equal to 1. When the protein is un-
folded, the parameter y = yu, and the fraction of unfolded protein fu is
equal to 1. For intermediate states, y is given by yf ff +yufu. Thus, by
measuring y, we can calculate the fraction of protein unfolded:
fu = (yf3y)/(yf3yu). The equilibrium constant for the unfolding pro-
cess is Ku = fu/(13fu) and melting temperatures (Tm) are obtained at
Ku = 1 [9].
2.6. ANSA £uorescence enhancement
Protein concentration was adjusted to 0.1 mg/ml in B/P pH 6.8 and
equilibrated at room temperature (RT) for 1 h. Then ANSA was
added to a ¢nal concentration of 10 WM and equilibrated 5 min prior
to measurements. Spectra were recorded using an LS50-B Perkin-El-
mer £uorometer with an excitation wavelength of 380 nm. Spectra
were collected from 410 to 550 nm. Correction for bu¡er signal on
ANSA was keyed in when applicable.
2.7. Intrinsic £uorescence measurements
Protein concentration of samples was adjusted to 0.1 mg/ml and
equilibrated at RT for 1 h. For chemical denaturation, urea (Sigma
U-5378) was added to a ¢nal concentration of 8 M and equilibrated at
RT 5 min before measurement. For thermal denaturation, temper-
ature was increased to 85‡C at a rate of 15‡C per hour using Neslab
RTE-11. Spectra were recorded using an L550-B Perkin-Elmer £uor-
ometer with an excitation wavelength of 280 nm. Spectra were then
corrected for bu¡er signal before analysis.
2.8. Size-exclusion chromatography/estimation of molecular size
Protein samples were adjusted to a concentration of 0.6 mg/ml and
loaded onto a Beckman Ultraspherogel SEC-2000 column hooked to
a Waters 510 HPLC. The column was standardized with the Pharma-
cia Low Molecular Weight gel ¢ltration calibration standards pre-
pared in the same bu¡er.
2.9. Proteolytic degradation measurements
Experiments were carried out as described by Krisnamoorty et al.
[10] ; with few modi¢cations as described in Morrison et al. [11]. Re-
actions were stopped by the addition of 2% SDS bu¡er followed by
heating for 3 min at 100‡C. Samples were then analyzed on SDS^
PAGE followed by silver nitrate staining. The amount of protein
remaining after incubation with proteases was determined by measur-
ing the OD of each band using the image analysis system Imaging
Research MCID. Cytochrome c from horse heart (Sigma C-7752) was
used as a reference protein for all degradation runs in order to correct
for possible variations in crude proteolytic activity.
3. Results
Position 62 in MB-1 was chosen for the emplacement of a
spectroscopic probe at the moment of initial design [1]. As
shown on the model in Fig. 1, this position is part of the
hydrophobic core, and a niche made of ¢ve Ala was built
Fig. 1. MB-1’s hydrophobic core as predicted by design. The in-
tended structure is a four-helix bundle, with residue polarity distrib-
uted along the canonical heptad pattern. The pictogram shows only
the interior of the bundle after ‘opening’ and ‘£attening’, each box
representing the non-polar face of a helix. Note that the large Tyr
in position 62 is surrounded by ¢ve small alanine residues.
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around it in order to accommodate a larger side chain in this
region of the core. Substitution of Tyr62 for Trp was per-
formed on MB-1 by site-directed mutagenesis and con¢rmed
by DNA sequencing and £uorospectroscopy (not shown);
then the mutant, named MB-1Trp, was characterized. First,
CD measurements were performed and spectra typical of hel-
ical proteins were obtained (Fig. 2). Using the CDsstr algo-
rithm [8], 50% of amide groups were predicted to be in a
helical environment. Thus, the secondary structures of the
mutant MB-1Trp were found to be similar to the parent mol-
ecule MB-1.
The formation of a tertiary structure in the mutant was
con¢rmed by £uorescence measurements: the folded protein
£uorescence peaked at 333 nm, and its emission shifted to
approximately 345 nm when unfolded using heat or urea
(Fig. 3). The Trp side chain appears to be protected in the
folded protein, and exposed to solvent upon unfolding, as
predicted by design. Similar shifts in £uorescence Vmax were
observed for another designer protein (K4) after insertion of a
Trp side chain [12].
Results from £uorescence measurements using the probe
ANSA are shown in Fig. 4. The enhancement of ANSA emis-
sion by the protein was limited to a factor of 3, which is
comparable to the parent molecule [4], and lower than the
values expected for poorly folded proteins [13]. These results
suggest that MB-1Trp is rather well folded, and not in a
molten globule. Size-exclusion chromatography analysis re-
vealed that MB-1Trp migrated as a 12 kDa protein, closed
to the expected size of an MB-1Trp monomer. Substitution of
Trp in position 62 appears to correct one weakness of the
initial design of MB-1, which had a size approaching that of
a dimer [4].
The impact of the substitution in position 62 on conforma-
tional stability was veri¢ed using two di¡erent approaches.
First, the CD signal at 222 nm was recorded at various tem-
peratures in order to monitor unfolding of MB-1Trp helices.
The denaturation of MB-1Trp (Fig. 5) indicated a melting
temperature of 55‡C, a signi¢cant improvement over MB-1
(melting temperature of 39‡C) and other mutants charac-
terized so far ([6], He¡ord and Beauregard, in prepara-
tion). The thermal denaturation was found to be fully revers-
Fig. 2. CD spectra of MB-1Trp. A 50% helical content was pre-
dicted from such spectra as described in Section 2.
Fig. 3. Unfolding of MB-1Trp as monitored by £uorospectroscopy.
Spectra were obtained for MB-1Trp at 20‡C (curve 1), after thermal
denaturation at 85‡C (curve 2) and after urea denaturation (curve
3).
Fig. 4. Enhancement of ANSA £uorescence by MB-1Trp. Spectra
collected with 10 WM ANSA alone (bottom curve) and ANSA with
MB-1Trp (top curve). When exposed to the mutant protein, ANSA
£uorescence shifts from 510 to 480 nm, and its £uorescence intensity
at 480 nm increases by a factor of 3, as a result of binding to hy-
drophobic clusters in folded MB-1Trp.
Fig. 5. Thermal denaturation curve for MB-1Trp. vO was measured
at 222 nm as described in Section 2.
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ible, another improvement over MB-1, but the transition was
spread over a wide temperature range (30^65‡C). However,
this apparent lack of cooperativity in MB-1Trp thermal un-
folding also characterized MB-1 and other small designer pro-
teins [6,12].
Stabilization of MB-1 fold by the mutation was also con-
¢rmed by proteolytic degradation experiments. Degradation
curves shown in Fig. 6 clearly demonstrate a gain in resistance
to proteolytic attack. Under our standard conditions, MB-
1Trp was twice as resistant as MB-1, and behaved like a
natural protein of similar size (cytochrome c).
4. Discussion
Trp and Tyr residues are comparable on various counts:
they have large aromatic side chains, they undergo a limited
but similar loss of conformational entropy upon protein fold-
ing, and they have similar secondary propensities [14,15].
They di¡er in their hydrophobicities, however, due to the
presence of a hydroxyl group in p position on the phenyl
moiety. When such a polar group is involved in a hydrogen
bond, the di¡erence between Trp and Tyr hydrophobicity
decreases [14], but in MB-1, no such H-bonding partner was
properly positioned while designing the protein. Most results
shown here indicate that the increase in hydrophobicity in
position 62, due to the removal of tyrosine’s hydroxyl group
from the core, led to an important improvement of MB-1 fold
stability. The important impact of a Tyr-Trp mutation ob-
served here is not totally unexpected: Honda et al. [16] ob-
served a signi¢cant drop in Tm values for the chitosanase from
Streptomyces sp. N174 upon removal of Trp residues. This
may be explained by tryptophan’s ability to make extensive
van der Waals contacts with neighboring residues due to its
large size, in addition to its contribution to the hydrophobic
e¡ect. The improvement of MB-1 properties also included the
speci¢cation of a monomeric organization. A full understand-
ing of such a correction to this design weakness awaits further
investigations though.
Trp and Tyr both belong to the class of large side chains,
but Trp is signi¢cantly larger than Tyr, with an additional 34
Aî 3 [16,17]. The original design strategy allowed for a Tyr in
position 62, but not for Trp, which would result in a layer
volume that would be above average for natural bundles. The
results shown here all indicate that MB-1 secondary and ter-
tiary structures were not disturbed by the substitution Tyr62-
Trp. The protein is helical and well folded and it appears that
the niche around position 62 readily accommodates the larger
side chain of Trp. The mutation resulted in an important
improvement in the protein stability. In a comparable design-
er protein where the intended location of a Trp was not en-
gineered in a way as to accommodate an increase in bulk, the
mutation actually destabilized the protein [12].
Our results suggest that while Trp stabilized MB-1 fold, it
may not be as buried as Tyr was in MB-1: its £uorescence
Vmax is at 333 nm, and not near 325 nm as observed for fully
protected Trp. Similar results obtained by Handel et al. [12]
on a similar designer protein may indicate that Trp cannot be
buried completely in a core as small as the one involved here.
The gain in conformational stability a¡orded by the Tyr62-
Trp mutation is of paramount importance for future advances
in the development of MB-1 family of proteins. What we
achieved here by a single point mutation is the conversion
of a low stability protein into a protein that is now folded
at physiological temperature. Its high resistance to proteases
could permit the production of this high quality protein by
transgenic crops to be used in animal production. A compar-
ison of previously reported analyses of plant protein degrad-
ability indicates that MB-1Trp compares to sun£ower 2S seed
albumin 8 protein, a protein with a high methionine content
intended for production of transgenic crops with enhanced
nutritional quality [18]. Note that the EAA pro¢le of SFA8
is not optimized for lactating cows needs, while MB-1Trp is,
due to its balanced content of methionine, lysine and threo-
nine. This comparison indicates that although few cycles of
design may be required, our design approach produced a high
quality protein that competes with natural proteins at the level
of stability.
A number of MB-1 mutants have been designed and char-
acterized so far. The design strategy was based on the assump-
tion that MB-1 folded as an K-helical bundle, as shown in Fig.
1. Most mutants, including MB-1Trp, behaved as helical and
folded protein ([7,19], Williams et al., in preparation). These
results (and results from investigations of MB-1 structure us-
ing a number of low resolution techniques) all indicate that
the designer protein MB-1 is approximately folded as planned.
Nevertheless, no detailed structure (nuclear magnetic reso-
nance or X-ray) is available for the designer protein MB-1
as of yet, since our e¡orts have been hampered by lack of
solubility and stability in solution [7]. The mutant presented
here clearly outperforms the parent molecule on several
counts, including the ability to stay monomeric under condi-
tions used here, and to resist degradation in solution. Crys-
tallization experiments are under way and it is hoped that
solving the MB-1Trp structure will permit a critical evaluation
of the design strategy used for MB-1.
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